SCM

Squadron Capital Management Portfolio holdings

AUM $250M
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
–
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$250M
AUM Growth
+$25.9M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
48
New
Increased
Reduced
Closed

Top Buys

1
+$9.38M
2
+$8.46M
3
+$8.4M
4
NKTR icon
Nektar Therapeutics
NKTR
+$7.12M
5
RLAY icon
Relay Therapeutics
RLAY
+$6.02M

Top Sells

1
+$10.3M
2
+$7.68M
3
+$6.55M
4
UPB
Upstream Bio Inc
UPB
+$6.26M
5
XENE icon
Xenon Pharmaceuticals
XENE
+$4.73M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TRAW icon
26
Traws Pharma
TRAW
$23.9M
$936K 0.37%
511,714
-201,826
TXMD icon
27
TherapeuticsMD
TXMD
$24.3M
$849K 0.34%
+420,421
SPRB
28
Spruce Biosciences
SPRB
$145M
$797K 0.32%
12,200
-57,800
HOWL icon
29
Werewolf Therapeutics
HOWL
$22.9M
$469K 0.19%
+563,535
NEUP
30
Neuphoria Therapeutics
NEUP
$29.4M
$312K 0.12%
+76,728
DBVT
31
DBV Technologies
DBVT
$1.08B
– –
-240,000
AVTX icon
32
Avalo Therapeutics
AVTX
$867M
– –
-130,000
BLTE
33
Belite Bio
BLTE
$5.5B
– –
-26,000
CMPS
34
Compass Pathways
CMPS
$1.64B
– –
-388,287
HELP
35
Cybin Inc
HELP
$222M
– –
-525,000
IDYA icon
36
IDEAYA Biosciences
IDYA
$2.56B
– –
0
KPTI icon
37
Karyopharm Therapeutics
KPTI
$194M
– –
0
NTLA icon
38
Intellia Therapeutics
NTLA
$1.75B
– –
0
TARS icon
39
Tarsus Pharmaceuticals
TARS
$2.64B
– –
-80,000
TERN
40
DELISTED
Terns Pharmaceuticals
TERN
– –
-190,000
VERA icon
41
Vera Therapeutics
VERA
$2.47B
– –
0
VTYX
42
DELISTED
Ventyx Biosciences
VTYX
– –
-410,000
WVE icon
43
Wave Life Sciences
WVE
$1.22B
– –
-175,000
XENE icon
44
Xenon Pharmaceuticals
XENE
$5.26B
– –
-105,551
AVBP icon
45
ArriVent BioPharma
AVBP
$1.29B
– –
0
ZBIO
46
Zenas BioPharma
ZBIO
$1.2B
– –
0
CLYM
47
Climb Bio
CLYM
$645M
– –
-100,000
UPB
48
Upstream Bio Inc
UPB
$446M
– –
-230,650
1
2